GENFIT TOWARDS BETTER MEDICINE
LIVE

Serial Number

87401101

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Apr 6, 2017

Add to watchlist:

No watchlists yet
View on USPTO

GENFIT TOWARDS BETTER MEDICINE Trademark

Serial Number: 87401101 • Registration: 5399953

GENFIT TOWARDS BETTER MEDICINE is a trademark filed by GENFIT on April 6, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (51 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

April 6, 2017

Registration Date

February 13, 2018

Published for Opposition

November 28, 2017

Goods & Services

Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; cultures of microorganism for medical, pharmaceutical or veterinary use; cells preparations for medical, pharmaceutical or veterinary use, in particular for gene therapy or cell therapy; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; food supplements

Professional consultancy, not connected with the conduct of business, in the field of hepatology, gastroenterology, cholestatic, cardiovascular, metabolic, inflammation, autoimmune therapy

Pharmaceutical research, namely, research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical and veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; screening and selection of molecules for scientific research purposes; development and validation of biological tests, of cell tests and of genetic tests; Functional analysis of genomics to identify, characterize, validate or develop biologically active molecules; analysis of biological substances in biologic fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering surveying; analysis of technical projects; professional consultancy, not connected with the conduct of business, in the field of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 5, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 4, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 4, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 6, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 13, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 26, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2017 CRFA
ASSIGNED TO LIE
Oct 11, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 14, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 13, 2017 NWOS
NEW APPLICATION ENTERED
Apr 10, 2017 NWAP